HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

Frías, M; Rodríguez-Cano, D; Cuenca-López, F; Macías, J; Gordon, A; Manzanares-Martín, B; Pineda, J A; Camacho, Á; Torre-Cisneros, J; Peña, J; Rivero-Juárez, A; Rivero, A

Frías, M; Rodríguez-Cano, D; Cuenca-López, F; Macías, J; Gordon, A; Manzanares-Martín, B; Pineda, J A; Camacho, Á; Torre-Cisneros, J; Peña, J; Rivero-Juárez, A; Rivero, A.

Affiliation

Frías M; Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Rodríguez-Cano D; Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Cuenca-López F; Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Macías J; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.
Gordon A; Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Manzanares-Martín B; Immunology Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Pineda JA; Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.
Camacho Á; Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Torre-Cisneros J; Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Peña J; Immunology Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Rivero-Juárez A; Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
Rivero A; Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.

Pharmacogenomics J ; 17(6): 551-555, 2017 12.

Article in En | MEDLINE | ID: mdl-27241060

Subject(s)

HIV Infections/drug therapy; HLA-B18 Antigen/genetics; Hepatitis C/drug therapy; Liver Cirrhosis/immunology; Adult; Coinfection; Disease Progression; Female; Genotype; HIV Infections/complications; HIV Infections/genetics; HIV Infections/virology; Hepatitis C/complications; Hepatitis C/genetics; Hepatitis C/virology; Humans; Liver Cirrhosis/etiology; Liver Cirrhosis/genetics; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Failure; Viral Load

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Hepatitis C / HLA-B18 Antigen / Liver Cirrhosis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenomics J Journal subject: BIOLOGIA MOLECULAR / FARMACOLOGIA Year: 2017 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google